Editors Choice
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
Access to targeted therapies for lung cancer depends on the accurate identification of patients’ biomarkers through molecular testing. The International Association for the Study of Lung Cancer (IASLC) conducted an international survey to evaluate perceptions on current practice and barriers to implementation of molecular testing.
